Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 12Phase 1/2 4Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Sarcoma 1Genitourinary 1Dermatologic 1

Conditions

Neuroblastoma 2Uveal Melanoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Osteosarcoma 1Melanoma 1Medulloblastoma 1Kidney Neoplasms 1Glioma 1Glioblastoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

pembrolizumab 210Cyclophosphamide 123Nivolumab 108Carboplatin 92fludarabine 82Gemcitabine 77Specimen Handling 74Bevacizumab 72venetoclax 70Injections 70Magnetic Resonance Spectroscopy 67Dexamethasone 66Paclitaxel 65Biopsy 59atezolizumab 56Cisplatin 55Ipilimumab 50Temozolomide 45Docetaxel 43Azacitidine 42Oxaliplatin 41Lenalidomide 41Pemetrexed 40Fluorouracil 40Rituximab 39Radiotherapy 39Cetuximab 37Capecitabine 37durvalumab 36Cytarabine 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all
NCT00458536 2026-05-19

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Beth Israel Deaconess Medical Center

Phase 1/2 Completed
38 enrolled 4 charts
Genitourinary

Kidney Neoplasms

NCT04238819 2026-03-02

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Eli Lilly and Company

Phase 1/2 Completed
47 enrolled 36 charts
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT01757626 2026-01-07

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
186 enrolled 1 FDA
CNS

Neuroblastoma

NCT06626516 2025-11-28

Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University

Phase 1/2 Recruiting
109 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡